Dengue

Dengue
Author: World Health Organization
Publisher: World Health Organization
Total Pages: 159
Release: 2009
Genre: Medical
ISBN: 9241547871


Download Dengue Book in PDF, Epub and Kindle

This publication is intended to contribute to prevention and control of the morbidity and mortality associated with dengue and to serve as an authoritative reference source for health workers and researchers. These guidelines are not intended to replace national guidelines but to assist in the development of national or regional guidelines. They are expected to remain valid for five years (until 2014), although developments in research could change their validity.--Publisher's description.

West Nile Virus Response Plan 2005

West Nile Virus Response Plan 2005
Author: Nova Scotia West Nile Virus Working Group
Publisher:
Total Pages: 56
Release: 2005
Genre: Mosquitoes
ISBN:


Download West Nile Virus Response Plan 2005 Book in PDF, Epub and Kindle

Establishing a West Nile Virus Prevention/response Program

Establishing a West Nile Virus Prevention/response Program
Author: Clayton D. Skinner
Publisher:
Total Pages: 26
Release: 2013
Genre:
ISBN:


Download Establishing a West Nile Virus Prevention/response Program Book in PDF, Epub and Kindle

Recommendations include the implementation of a surveillance program that includes the identification of mosquito breeding locations, a prevention program that includes the distribution of items such as insect repellant and larvicide briquettes and a response program to mitigate further spread of WNV.

The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic

The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic
Author: Institute of Medicine
Publisher: National Academies Press
Total Pages: 440
Release: 2010-07-04
Genre: Medical
ISBN: 0309146771


Download The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic Book in PDF, Epub and Kindle

In March and early April 2009, a new, swine-origin 2009-H1N1 influenza A virus emerged in Mexico and the United States. During the first few weeks of surveillance, the virus spread by human-to-human transmission worldwide to over 30 countries. On June 11, 2009, the World Health Organization (WHO) raised the worldwide pandemic alert level to Phase 6 in response to the ongoing global spread of the novel influenza A (H1N1) virus. By October 30, 2009, the H1N1 influenza A had spread to 191 countries and resulted in 5,700 fatalities. A national emergency was declared in the United States and the swine flu joined SARS and the avian flu as pandemics of the 21st century. Vaccination is currently available, but in limited supply, and with a 60 percent effectiveness rate against the virus. The story of how this new influenza virus spread out of Mexico to other parts of North America and then on to Europe, the Far East, and now Australia and the Pacific Rim countries has its origins in the global interconnectedness of travel, trade, and tourism. Given the rapid spread of the virus, the international scientific, public health, security, and policy communities had to mobilize quickly to characterize this unique virus and address its potential effects. The World Health Organization and Centers for Disease Control have played critical roles in the surveillance, detection and responses to the H1N1 virus. The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic: Global Challenges, Global Solutions aimed to examine the evolutionary origins of the H1N1 virus and evaluate its potential public health and socioeconomic consequences, while monitoring and mitigating the impact of a fast-moving pandemic. The rapporteurs for this workshop reported on the need for increased and geographically robust global influenza vaccine production capacities; enhanced and sustained interpandemic demand for seasonal influenza vaccines; clear "triggers" for pandemic alert levels; and accelerated research collaboration on new vaccine manufacturing techniques. This book will be an essential guide for healthcare professionals, policymakers, drug manufacturers and investigators.